WO2012097368A3 - Her3 and her4 primers and probes for detecting her3 and her4 mrna expression - Google Patents
Her3 and her4 primers and probes for detecting her3 and her4 mrna expression Download PDFInfo
- Publication number
- WO2012097368A3 WO2012097368A3 PCT/US2012/021546 US2012021546W WO2012097368A3 WO 2012097368 A3 WO2012097368 A3 WO 2012097368A3 US 2012021546 W US2012021546 W US 2012021546W WO 2012097368 A3 WO2012097368 A3 WO 2012097368A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- her3
- her4
- detecting
- primers
- probes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to methods, primers and probes useful for detecting the presence of HER1, HER 2, HER3 and/or HER 4 sequences or a combination thereof, in a sample, specifically for measuring the expression levels in the sample. The invention provides oligonucleotide primer pairs and methods comprising their use for detecting levels of HER1, HER 2, HER3 and/or HER 4 mRNA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161432933P | 2011-01-14 | 2011-01-14 | |
| US61/432,933 | 2011-01-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012097368A2 WO2012097368A2 (en) | 2012-07-19 |
| WO2012097368A3 true WO2012097368A3 (en) | 2014-04-10 |
Family
ID=46507705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2012/021546 Ceased WO2012097368A2 (en) | 2011-01-14 | 2012-01-17 | Her3 and her4 primers and probes for detecting her3 and her4 mrna expression |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012097368A2 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020192652A1 (en) * | 2001-06-11 | 2002-12-19 | Danenberg Kathleen D. | Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates |
| US20040157255A1 (en) * | 2003-02-06 | 2004-08-12 | David Agus | Gene expression markers for response to EGFR inhibitor drugs |
| US20070065845A1 (en) * | 2002-03-13 | 2007-03-22 | Baker Joffre B | Gene expression profiling in biopsied tumor tissues |
| US20080026393A1 (en) * | 2006-05-25 | 2008-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby |
| US20100008975A1 (en) * | 2007-03-02 | 2010-01-14 | Amler Lukas C | Predicting response to a HER inhibitor |
-
2012
- 2012-01-17 WO PCT/US2012/021546 patent/WO2012097368A2/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020192652A1 (en) * | 2001-06-11 | 2002-12-19 | Danenberg Kathleen D. | Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates |
| US20070065845A1 (en) * | 2002-03-13 | 2007-03-22 | Baker Joffre B | Gene expression profiling in biopsied tumor tissues |
| US20040157255A1 (en) * | 2003-02-06 | 2004-08-12 | David Agus | Gene expression markers for response to EGFR inhibitor drugs |
| US20080026393A1 (en) * | 2006-05-25 | 2008-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby |
| US20100008975A1 (en) * | 2007-03-02 | 2010-01-14 | Amler Lukas C | Predicting response to a HER inhibitor |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012097368A2 (en) | 2012-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201317477D0 (en) | Methods, compositions and kits for determing the presence/absnece of a variant nucleic acid sequence | |
| WO2013022786A3 (en) | Microrna biomarkers | |
| WO2013033609A3 (en) | Methods and compositions for the treatment and diagnosis of cancer | |
| WO2010120853A3 (en) | Methods and compositions to detect and differentiate small rnas in rna maturation pathway | |
| EA201600085A1 (en) | KIT FOR DETECTION OF SOYO SYNT SYNT0H2 EVENT | |
| MX338296B (en) | Compositions and methods for quantifying a nucleic acid sequence in a sample. | |
| EP3971299A3 (en) | Colorectal cancer detection kit or device, and detection method | |
| EP3967769A3 (en) | Lung cancer detection kit or device, and detection method | |
| EP3816302A3 (en) | Esophageal cancer detection kit or device, and detection method | |
| WO2010009337A3 (en) | Signatures and pcdeterminants associated with prostate cancer and methods of use thereof | |
| HK1246828A1 (en) | Biomarker panel for the detection of cancer | |
| MY170983A (en) | Biomarker assays for detecting or measuring inhibition of tor kinase activity | |
| IL218021A0 (en) | Methods, primers, probes and kits useful for the detection of braf mutations | |
| WO2010075360A3 (en) | Methods for detection of sepsis | |
| WO2013106844A3 (en) | Methods and compositions for the treatment and diaginosis of pancreatic cancer | |
| WO2012075069A3 (en) | Signatures and determinants associated with cancer and methods of use thereof | |
| EP2557156A4 (en) | Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same | |
| WO2012164525A3 (en) | Aging biomarkers | |
| WO2013028544A3 (en) | Compositions and methods for detecting and discriminating between yeast or mold | |
| HK1252265A1 (en) | Nucleic acid detection and quantification method and compositions | |
| WO2012089753A3 (en) | Complex sets of mirnas as non-invasive biomarkers for glioblastoma | |
| AP2011005866A0 (en) | Oligonucleotide probes and primers for detection of hepatitus B virus. | |
| SG168423A1 (en) | Influenza detection method and kit therefor | |
| HK1231512A1 (en) | Methods for detecting multiple nucleic acids in a sample | |
| SG196715A1 (en) | Compositions for detecting foodstuff spoilage microorganisms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12734748 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12734748 Country of ref document: EP Kind code of ref document: A2 |